Role of single and mixed probiotics in acute diarrheal diseases in pediatric population


  • Ambrish Gupta Department of Pharmacology, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India
  • Prashant Maheshwari Department of Pharmacology, Rainbow Medical Centre, Kanpur, Uttar Pradesh, India
  • Y. K. Rao Department of Paediatrics, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India



Acute diarrhoeal disease, Probiotics, Paediatric population


Background: The objective of present study was to analyse the effect of probiotics on various parameters of acute diarrhoeal disease and to compare single and mixed probiotic preparations in context to their role in acute diarrhoeal disease in paediatric population.

Methods: A double blind controlled trial was conducted in children suffering from acute diarrhoeal disease at department of paediatrics jointly with department of pharmacology, G. S. V. M. Medical college, Kanpur, U.P., India. All enrolled children were divided into three groups having similar baseline characteristics. One group was given single probiotic preparation another mixed probiotic preparation and the third one (i.e. control group) placebo plus Zinc/ORS to all three groups. Various parameters such as frequency and consistency of stool, duration of diarrhoea were measured after doing intervention over a period of one week.

Results: In our study duration of diarrhoea, stool frequency and total duration of hospital stay was found significantly less in probiotic groups compared to control group. However no significant difference was found between single and mixed probiotics in curtailing the acute diarrhoeal illness.

Conclusions: Probiotics should be used judiciously in acute diarrhoeal diseases. There is no additional benefit of mixed probiotics in acute diarrhoeal diseases rather than increasing the cost of treatment.


Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrheal disease: a ten-year update. Bull World Health Organ. 1992;70:705-14.

Santosham M, Keenan EM, Tulloch J, Broun D, Glass R. Oral rehydration therapy for diarrhoea: an example of reverse transfer of technology. Pediatrics. 1997;100:E10.

Mougi M, el-Akkad N, Hendawi A, Hassan M, Amer A, Fontaine O, Pierce NF. Is a low-osmolarity ORS solution more efficaciousthan standard WHO ORS solution. J Pediatr Gastroenterol Nutr. 1994;19(1):83-6.

Choice Study Group. Multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of a reduced osmolarity oral rehydration salts solution in children with acute watery diarrhea. Pediatrics. 2001;107:613-8.

Rautanen T, Isolauri E, Salo E, Vesikari T. Management of acute diarrhoea with low osmolarity oral rehydration solutions and Lactobacillus strain GG. Arch Dis Child. 1998;79:157-60.

Costa-Ribeiro H, Ribeiro TC, Mattos AP, Valois SS, Neri DA, Almeida P, et al. Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr. 2003;36(1):112-5.

Pazzaglia G, Sack RB, Salazar-Lindo E, Yi A, Chea E, Leon-Barua R, et al. High frequency of coinfectingenteropathogensin Aeromonas- associated diarrhea of hospitalized Peruvian infants. J Clin Microbiol. 1991;29:1151-6.

Pant AR, Graham SM, Allen SJ, Harikul S, Sabchareon A, Cuevas L, et al. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr. 1996;42(3):16-25.

Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995;20(3):33-8.

Guarino A,Canani RB, Spagnuolo MI, Albano F, Di Benedetto L. Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhoea. J Pediatr Gastroenterol Nutr. 1997;25(5):51-69.

Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatric Gastroenterol Nutr. 2000;30(1)54-60.

Isolauri E, Kaila M, Mykkänen H, Ling WH, Salminen S. Oral bacteriotherapy for viral gastroenteritis. Dig Dis Sci. 1994;39(12):2595-600.

Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatric Gastroenterol Nutr. 2011;33:S11-25.

Salazar-Lindo E, Miranda-Langschwager P, Campos-Sanchez M, Chea-Woo E, Sack RB. Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhoea: a randomized, double blind, placebo controlled clinical trial. BMC Paediatrics. 2004;4:18.

Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute non-bloody diarrhea. Pakistan Pediatr Infect Dis J. 1995;14(2):107-11.

Htwe K, Yee KS, Tin M, Vandenplas Y. Effect of Saccharomyces boulardii in the treatment of acute watery diarrhea in Myanmar children. a randomized controlled study. Am J Trop Med. Hyg. 2008;78(2):214-6.




How to Cite

Gupta, A., Maheshwari, P., & Rao, Y. K. (2017). Role of single and mixed probiotics in acute diarrheal diseases in pediatric population. International Journal of Basic & Clinical Pharmacology, 6(11), 2596–2600.



Original Research Articles